Skip to content

Exploring the Spectrum of Autoimmune Hepatitis: Acute, Acute-on-Chronic, and Chronic Forms

Exploring the Spectrum of Autoimmune Hepatitis: Acute, Acute-on-Chronic, and Chronic Forms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093347
Enrollment
Unknown
Registered
2024-12-03
Start date
2024-12-05
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune hepatitis

Interventions

Acute AIH:None
Acute-on-Chronic AIH:None
Chronic AIH:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosed as "definitive AIH" according to the revised IAIHG score or simplified IAIHG score; 2) Have clear histological evidence and receive immunosuppressive therapy; 3) Acute AIH is characterized by meeting at least one of the following three criteria during the course of the disease: a) TB >=5mg /dL, b) ALT >=10×ULN, c) AST >=10xULN. At the same time, patients with acute AIH must meet the requirements of =26 weeks, b) liver histology S >=2, and c) radiographic cirrhosis. Patients with chronic AIH do not have the acute AIH symptoms described above.

Exclusion criteria

Exclusion criteria: 1) Other autoimmune liver diseases (primary biliary cholangitis/cirrhosis, primary sclerosing cholangitis, overlap syndrome); 2) With other chronic liver diseases and AIH is not the main cause, including viral hepatitis, alcoholic liver disease, metabolically related fatty liver disease, drug-induced liver injury, hereditary liver disease, etc.; 3) Lack of key diagnosis and treatment data (such as key tests or examinations, medication information, clinical events, etc.).

Design outcomes

Primary

MeasureTime frame
Full biochemical remission rate;Death;Relapse;liver transplantation;

Secondary

MeasureTime frame
Time to obtain complete remission;

Countries

China

Contacts

Public ContactYang Li

West China Hospital, Sichuan University

yangli_hx@scu.edu.cn+86 189 8060 1276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026